HomeNewsBusinessEconomyPreview | Low base may see Q1 GDP growth hit record, conceal second-wave impact

Preview | Low base may see Q1 GDP growth hit record, conceal second-wave impact

India’s GDP growth contracted 24.4 percent during the first quarter last year. In absolute terms, the economic recovery has still not reached pre-pandemic levels, going by the RBI’s projections. The GDP data will be released on August 31.

August 31, 2021 / 13:57 IST
Story continues below Advertisement
Economic activity in the April-June quarter benefited from healthy Central and State government capital spending, robust merchandise exports, and resilient demand from the farm sector, according to Aditi Nayar, Chief Economist with Icra Ltd.
Economic activity in the April-June quarter benefited from healthy Central and State government capital spending, robust merchandise exports, and resilient demand from the farm sector, according to Aditi Nayar, Chief Economist with Icra Ltd.

India’s economy is expected to show growth in double digits for the first quarter of fiscal year 2021-22 (April-June), largely because of the low base from the same quarter last year, when a nationwide lockdown was imposed due to the Covid-19 pandemic. In fact, it could be a record high for quarterly gross domestic product (GDP) growth.

Nevertheless, the economic bounce-bank is expected to be tempered by the reduction in consumption brought about by the deadly second wave of the pandemic, which began to hit hard in April and May this year.

Story continues below Advertisement

Also Read | What to look for in the Q1 GDP numbers

The National Statistical Office will release the Q1 GDP data on the evening of August 31.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show